The Objectives of the UCSF Microbial Pathogenesis and Host Defense (MPHD) program are to provide world class training and research for graduate students and postdoctoral fellows at UCSF by creating a coherent and cohesive community comprised of diverse world class laboratories studying all aspects of microbial pathogenesis. World-wide, infectious diseases are a leading cause of death. The study of microbial pathogenesis is a rapidly advancing area of research, with unprecedented opportunity to influence health worldwide through the development of new preventative, therapeutic, and diagnostic strategies. The MPHD program at UCSF offers a world class training program that currently is comprised of 27 faculty training 59 graduate students, and 128 postdoctoral fellows. 5 faculty members were newly recruited to UCSF to join the program in the past 6 years. Areas of active research include the pathogenesis of malaria, TB, schistosomiasis, HIV, fungal pathogens, and gram negative and gram positive infections. The MPHD program is designed to provide a solid background in genetics, cell biology, molecular biology, and mammalian tissue and organ biology as well as thorough training in microbial pathogenesis. The Interdisciplinary nature of this training is enhanced by the affiliation of the MPHD Program with the UCSF Biomedical Sciences Program (BMS) and Program in Biomedical Sciences (PIBS), interdisciplinary graduate programs through which graduate students enter the MPHD program. The MPHD training program includes (i) a weekly seminar series comprised of outside invited speakers, research-in-progress talks from students and postdocs in the program (ii) a graduate level course entitled """"""""Molecular Mechanisms of Microbial Pathogenesis"""""""" offered every other spring as an elective for graduate students that can be audited by postdoctoral fellows (iii) a yearly bay area wide day symposium with student, postdoc, and faculty speakers, an outside invited keynote speaker, and a poster session that is offered free of charge (iv) Microbial pathogenesis sessions at the two main yearly graduate program retreats (Biomedical Science Program and Program in Biological Sciences) (v) support for 4 graduate students and 2 postdocs through this T32 training grant (vii) a website with up to date information about the MPHD program and its activities as well as links to other relevant websites.

Public Health Relevance

Infectious disease is a leading cause of death, despite availability of antibiotics, vaccines, and advanced hygienic standards. Strategies for the prevention, treatment, and control of infectious diseases will require fundamental bench and translational research. The study of microbial pathogenesis is a rapidly advancing area of research, with unprecedented opportunity to influence health worldwide.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Institutional National Research Service Award (T32)
Project #
5T32AI060537-08
Application #
8078131
Study Section
Microbiology and Infectious Diseases B Subcommittee (MID)
Program Officer
Mcsweegan, Edward
Project Start
2004-08-01
Project End
2014-07-31
Budget Start
2011-08-01
Budget End
2012-07-31
Support Year
8
Fiscal Year
2011
Total Cost
$285,590
Indirect Cost
Name
University of California San Francisco
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Binning, Jennifer M; Smith, Amber M; Hultquist, Judd F et al. (2018) Fab-based inhibitors reveal ubiquitin independent functions for HIV Vif neutralization of APOBEC3 restriction factors. PLoS Pathog 14:e1006830
Shenoy, Meera K; Lynch, Susan V (2018) Role of the lung microbiome in HIV pathogenesis. Curr Opin HIV AIDS 13:45-52
Dolan, Patrick T; Whitfield, Zachary J; Andino, Raul (2018) Mapping the Evolutionary Potential of RNA Viruses. Cell Host Microbe 23:435-446
Dornfeld, Dominik; Dudek, Alexandra H; Vausselin, Thibaut et al. (2018) SMARCA2-regulated host cell factors are required for MxA restriction of influenza A viruses. Sci Rep 8:2092
Borges, Adair L; Davidson, Alan R; Bondy-Denomy, Joseph (2017) The Discovery, Mechanisms, and Evolutionary Impact of Anti-CRISPRs. Annu Rev Virol 4:37-59
Keck, Kristin M; Moquin, Stephanie A; He, Amanda et al. (2017) Bromodomain and extraterminal inhibitors block the Epstein-Barr virus lytic cycle at two distinct steps. J Biol Chem 292:13284-13295
Rauch, Benjamin J; Silvis, Melanie R; Hultquist, Judd F et al. (2017) Inhibition of CRISPR-Cas9 with Bacteriophage Proteins. Cell 168:150-158.e10
Bouquet, Jerome; Melgar, Michael; Swei, Andrea et al. (2017) Metagenomic-based Surveillance of Pacific Coast tick Dermacentor occidentalis Identifies Two Novel Bunyaviruses and an Emerging Human Ricksettsial Pathogen. Sci Rep 7:12234
Fontana, Mary F; de Melo, Gabrielly L; Anidi, Chioma et al. (2017) Correction: Macrophage Colony Stimulating Factor Derived from CD4+ T Cells Contributes to Control of a Blood-Borne Infection. PLoS Pathog 13:e1006192
Ruch, Travis R; Bryant, David M; Mostov, Keith E et al. (2017) Par3 integrates Tiam1 and phosphatidylinositol 3-kinase signaling to change apical membrane identity. Mol Biol Cell 28:252-260

Showing the most recent 10 out of 107 publications